Fasturtec TLS Treatment / Prophylysis
NCT00651911
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumor Lysis Syndrome
Interventions
DRUG:
urate oxidase
Sponsor
Sanofi